ROSE Diagnostics

Carlsbad, CA · Founded 2023 · Privately Held (backing)

Developer of lymph biomarkers designed for cancer diagnostics. ROSE Diagnostics is based in Carlsbad, CA and was founded in 2023. It has raised $3.4 million across 2 recorded rounds; the latest was a $2.3 million seed round in May 2025.

Last price · $/share
—
Implied valuation
—
Total raised
$3.4M
Last round
Seed Round
May 2025
How much has ROSE Diagnostics raised?
$3.4Macross 2 recorded rounds · Jun 2024 – May 2025

Most recently, ROSE Diagnostics raised $2.3M in its Seed Round (May 2025).

Private Market View
More of ROSE Diagnostics with a free Private Market View account
  • ·Watch ROSE Diagnostics: the Monday email on marks, rounds and moves
Create free account
No card required

Membership and data by Private Market View

ROSE Diagnostics round by round

2 rounds
May 2025Seed Round$2.3MSEC filing▮
18 investors participated
Jun 2024Seed Round$1.0MSEC filing▮
13 investors participated

How much has ROSE Diagnostics raised?

ROSE Diagnostics has raised $3.4 million across 2 recorded rounds since 2024. The largest was a $2.3 million seed round in May 2025.

ROSE Diagnostics has filed 2 Form Ds with the SEC since 2024, most recently in May 2025 ($2.3 million sold to 18 investors).

Frequently asked about ROSE Diagnostics

How much has ROSE Diagnostics raised?
ROSE Diagnostics has raised $3.4M in total across 2 recorded funding rounds.
When was ROSE Diagnostics's last funding round?
ROSE Diagnostics's most recent recorded round was Seed Round in May 2025, raising $2.3M.